10-K: BIO-key International 2025 Annual Report Analysis
Annual Report
BIO-key International reports a net loss of $7.16 million for 2025 amid ongoing liquidity challenges and Nasdaq delisting.
Summary
- Reported total revenue of $5.94 million for 2025, a 14% decrease from $6.93 million in 2024.
- Net loss widened to $7.16 million in 2025 compared to $4.30 million in 2024.
- Recorded a $2.5 million impairment charge on its investment in Boumarang, Inc.
- Operating expenses increased to $11.39 million, driven by the impairment charge.
- Cash and cash equivalents were $2.69 million as of December 31, 2025.
- The company is currently trading on OTC Markets following suspension from Nasdaq on May 13, 2026.
Sentiment
Score: 2
Explanation: StockSavvy.ai views this as highly negative due to the going concern warning, widening losses, and the suspension of the company's stock from the Nasdaq exchange.
Positives
- Hardware revenue grew 112% to $1.34 million in 2025.
- Successfully sold slow-moving inventory, resulting in a $513,400 reversal of hardware reserves.
- Maintained a customer base of over 600 customers globally.
- Recurring maintenance and support revenue increased by 4%.
Negatives
- Significant decline in license fee revenue, down 34% to $3.42 million.
- Widening net loss of $7.16 million.
- Substantial doubt regarding the company's ability to continue as a going concern.
- Suspension of common stock from the Nasdaq Capital Market.
Risks
- History of operating losses and negative cash flow.
- Dependence on external debt and equity financing to fund operations.
- Potential delisting from Nasdaq and reduced liquidity on OTC Markets.
- Cybersecurity threats, including nation-state actors and ransomware.
- Concentration risk with two customers accounting for 26% of revenue.
- Uncertainty regarding the recoverability of the investment in Boumarang, Inc.
Future Outlook
The company plans to focus on expanding its IAM market presence, pursuing large-scale identification projects, and growing its channel alliance program. It aims to maintain monthly operating expenses at approximately $750,000 and expects revenue growth to alleviate going concern doubts within the next twelve months.
Management Comments
- Management believes that biometrics should continue to play a key role in remote user authentication.
- The company expects that the compatible, yet superior portable biometric user experience offered by its technology for Windows 10 users will accelerate the demand for its computer network log-on solutions.
Industry Context
StockSavvy.ai notes that the IAM sector is shifting toward Zero Trust and CARTA security models. BIO-key's focus on 'Identity-Bound Biometrics' attempts to differentiate it from mainstream MFA providers, though it faces intense competition from larger, better-capitalized players like Okta, Ping, and Microsoft.
Comparison to Industry Standards
- BIO-key's revenue scale is significantly smaller than major IAM competitors like Okta or Ping Identity.
- The company's reliance on hardware accessories is a niche strategy compared to the software-only focus of most modern IDaaS providers.
- The company's financial position and going concern status are significantly weaker than industry benchmarks for publicly traded technology firms.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Reverse Stock Split | Effected a 1-for-10 reverse stock split effective April 30, 2026. | 2026-04-30 | Increased share price to meet Nasdaq minimum bid requirements, though the company was subsequently suspended for other reasons. |
Legal Proceedings
- The company is not currently a party to any pending lawsuits.
Related Party Transactions
- Collaboration with Fiber Food Systems, Inc. involving the purchase of Boumarang, Inc. shares.
Stakeholder Impact
- Shareholders face significant dilution risk from potential future capital raises.
- Investors face liquidity risks due to the stock trading on OTC Markets.
- Employees and creditors face uncertainty regarding the company's long-term viability.
Next Steps
- Attend Nasdaq Hearings Panel appeal on June 16, 2026.
- Continue efforts to regain compliance with Nasdaq listing standards.
- File overdue periodic reports with the SEC.
- Explore opportunities to sell or return inventory related to Nigerian projects.
Key Dates
| Date | Description |
|---|---|
| 2025-01-15 | Warrant exercise agreement with institutional investor. |
| 2025-09-30 | Issuance of $1.13 million senior secured promissory note. |
| 2025-10-27 | Warrant exercise agreement and partial prepayment of 2025 Note. |
| 2026-04-30 | Effective date of 1-for-10 reverse stock split. |
| 2026-05-13 | Suspension of trading on Nasdaq Capital Market. |
| 2026-06-16 | Scheduled hearing with Nasdaq Hearings Panel regarding appeal. |
Recommendation
sellThe combination of a going concern warning, widening net losses, and the suspension of trading on a major exchange indicates severe financial distress, making the stock highly speculative and risky for institutional or conservative investors.
Keywords
biometric authentication, identity and access management, cybersecurity, multi-factor authentication, BKYI, IAM, PortalGuard
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.